Contact: 
Balázs ERDEI  
innovation manager, ELTE Center for Innovation 
E-mail: erdei.balazs@innovacio.elte.hu  

ELTE-SOFT  

ELTE-Soft, established in 2008 and owned by ELTE, offers wide opportunities for cooperation in the private sector and in governmental/public administration. The company’s mission is to promote ELTE’s emergence as the focal point of national research and a training centre in the field of ICT software technologies. 

Contact: László GÁBORI 
E-mail: lgabori@elte.hu 
Further information HERE 

IMMUNOGENES  

ImmunoGenes was established in 2007 by Imre KACSKOVICS, with a fortunate scientific breakthrough. Since then the technology has been patented and used several times. The biotech company had two main profiles: developing custom-made antibodies and developing transgenic animals. The non-proprietary use of this innovative technology, protected by an international patent, was acquired in 2014 by the Japanese Kyowa Hakko Kirin Group to develop therapeutic monoclonal antibodies. They are involved in numerous collaborative research programmes (e.g. Hungarian Research Network – Institute of Experimental Medicine, Hungarian Research Network – Centre for Natural Sciences, University of Szeged, Semmelweis University and New York University). The company has been listed in "100 Most Interesting Hungarian Innovations". 

Contact: Imre KACSKOVICS 
E-mail: imre.kacskovics@immunogenes.com 
Further information HERE 

ESTRATO   

Estrato Research and Development Ltd. has several years of experience in the design and construction of highly innovative instruments for industry, and for medical and meteorological institutes. The company was established in 2004 to exploit the results of research conducted in the ELTE Environmental Optics Laboratory. Since then, Estrato Ltd. has been involved in several other research and development projects. 

Contact: András BARTA 
E-mail: info@estrato.hu 
Further information HERE 

EVOLVERITAS BIOTECHNOLOGY LTD.  

EvolVeritas Ltd. is a spinoff biotech company founded by scientists studying the molecular mechanism of complement activation through structure-driven protein engineering, directed protein evolution and enzymology. The mission of the company is to exploit and further develop the practical results of academic discoveries, which open up new avenues for the treatment of serious diseases with high unmet medical need. Researchers from ELTE and the Institute of Enzymology of the Hungarian Research Network – Centre for Natural Sciences have developed several generations of complement protease inhibitors. One of their lead compounds is under development for the treatment of various complement-related diseases. The company owns IP rights for the lead compounds. 

Contact: Gábor PÁL 
E-mail: palgabor@elte.hu, gabor.pal@evolveritas.com 
Further information HERE 

COLLEYEDER   

András LŐRINCZ and Zsolt PALOTAI have developed numerous algorithms (e.g. image and video processing algorithms and proof-of-concept software; word interpretation, expansion, ontology merging and document retrieval algorithms and proof-of-concept software) in recent years. Colleyeder was created to exploit the research findings of the ELTE Neural Information Processing Group in real world applications. 

Contact: Zoltán TŐSÉR 
E-mail: zoltan.toser@gmail.com  

VELGENE BIOTECHNOLOGY LTD. 

Velgene is a biotech enterprise focusing on autophagy related disorders.  The company was founded by a group of scientists (e.g. Tibor VELLAI, ELTE Department of Genetics) to develop drug candidates for influencing autophagic activity in order to treat certain disorders.  

Contact: Attila ERDŐS  
E-mail: attila.erdos@velgene-biotech.com, erdos.attila@gmail.com 

ARGUS COGNITIVE 

Argus produces medical software with advanced biometric solutions that assist healthcare professionals in making improved, more accurate clinical decisions. A related invention by András LŐRINCZ was assigned by ELTE to Argus Cognitive.  

Contact: Zoltán TŐSÉR 
E-mail: zoltan.toser@gmail.com 

DIAGNOSTICUM Inc. 

József PRECHL's invention “Antigen complement activation for the characterization of the immune response” was licensed by ELTE and the Hungarian Academy of Sciences to Diagnosticum Inc. in 2008. The company focuses on providing full laboratory service and offering innovative clinical chemistry solutions to meet customers’ requirements. 

Contact: Ferenc PÉTERFY 
E-mail: peterfy@diagnosticum.hu 
Further information HERE 

DATALYZE RESEARCH 

Datalyze is a multidisciplinary team of researchers and consultants (including sociologists, data scientists, mathematicians, psychologists, and marketing professionals), through whose work interdisciplinarity becomes a creative reality. They offer a unique blend of research, strategy, and data to inform and inspire new marketing solutions and decisions.  

Contact: Anna SÜTŐ 
E-mail: hello@datalyze.eu 
Further information HERE 

VELLAB BIOTECH LTD. 

ELTE has granted exclusive exploitation rights to Vellab Biotech Ltd. for the know-how of Tibor VELLAI and Ádám STURM (ELTE Department of Genetics) “Determining age from DNA”. 

COLLMOT ENTERTAINMENT 

CollMot was founded in 2015 by scientists working at the Robotics Laboratory of the ELTE Department of Biological Physics, as pioneers of autonomous drone swarm technology inspired by nature. As experts in collective robotics, they have developed a system in which their drones think interactively and fly autonomously, constantly communicating and cooperating with each other.  They take pride in having launched several world firsts for entertainment applications, from spectacular drone fireworks through aerial laser projections to drone light paintings.  

Contact: Gábor VÁSÁRHELYI 
E-mail: info@collmot.com 
Further information HERE 

MOTORPHARMA KFT. 

Motorpharma Ltd. is the most dynamically developing spin-off company established by András MÁLNÁSI-CSIZMADIA for the development and exploitation of innovative ideas. The Málnási-laboratory at ELTE has been one of the flagships of actin-myosin motor protein research for the last two decades. MPH-220, the leading drug candidate of Motorpharma Ltd. was successfully licensed to Motric Bio Inc.; the success of this commercial agreement was selected by Forbes as the most important Hungarian story of 2021. The company announced in December 2023 that the administration of the first-in-human clinical phase of the compound MPH 220/MTR 601 had started and was being conducted by Motric Bio. This is the first patent registered by ELTE in the United States.   

Contact: Anna RAUSCHER 
E-mail: anna.rauscher@motorpharma.com, info@motorpharma.com 
Further information HERE  

ENTREMO Ltd. 

ENTREMO supports healthcare workers by introducing smart digital solutions in manual processes. The IoT connected, sensor-equipped device is worn by patients in non-intensive care, enabling nurses to utilize their time more efficiently. The device was jointly developed by ELTE, ELTE Soft and ENTREMO Ltd. Entremo was awarded first place in Digital Health by Vodafone Hungary in their 2021 Awards ceremony.  

Contact: Péter LAKATOS 
E-mail: peter.lakatos@entremo.com 
Further information HERE